Search
ResApp chief executive Tony Keating.

ResApp raises $12.5m

Medical technology company ResApp Health has tapped investors for a $12.5 million capital raising to help push its technology into the US market.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/08/18

1 year TSR5 year TSR
44thResApp Health210%101%
124thPeppermint Innovation70%-15%
396thOrthocell2%0%
737 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

05/10/17
$65k Bought
16/12/16
$49k Bought
16/12/16
$49k Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

161st-Cre8tek$1.0m
162nd↑ResApp Health$999k
164th↓Peppermint Innovation$908k
165th↓Orthocell$884k
237 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from ResApp Health

183rdTony Keating$537k
995thBrian Leedman$78k
318thRoger Aston$72k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer